IL-36 Receptor Antagonist Suppresses Retinal Neovascularization and Vascular Leakage
Researchers found that administering recombinant interleukin-36 receptor antagonist reduced abnormal retinal blood vessel growth and vascular leakage while restoring barrier ...





